Thought Field Therapy and Cognitive Therapy for Agoraphobia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-10-31

Study Completion Date

2010-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose for this study is to find out if Thought field therapy has the same effect as, or better effect than, Cognitive therapy for Agoraphobia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder?

NCT00202709

Agoraphobia Social Phobia PTSD

COMPLETED NA

Residential Cognitive and Interpersonal Therapy for Social Phobia

NCT00326430

Social Phobia

COMPLETED PHASE2/PHASE3

Written Exposure Therapy for Post-traumatic Stress Syndrome

NCT04328935

Post Traumatic Stress Disorder

UNKNOWN NA

Effectiveness of Trauma Treatment in the Specialist Health Care Services

NCT06691347

Post Traumatic Stress Disorder PTSD Quality of Life Functional Outcome +3 more

RECRUITING NA

Comparing Cognitive Behaviour Therapy (CBT) With Metacognitive Therapy (MCT) in the Treatment of GAD

NCT00426426

Generalized Anxiety Disorder

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Thought field therapy is an alternative treatment method that has shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 72 patients will be randomized to three groups. 24 patients will receive cognitive therapy as a control method, 24 patients will receive thought field therapy. The remaining 24 patients will wait three months, and then be randomized to either of the two therapies.

Before inclusion all patients will be diagnosed with M.I.N.I. and SCID II. They will fill out self evaluation forms for symptoms and quality of life, before and after treatment, and one year after treatment.

All patients will undergo an interview with ADIS on panic and agoraphobic diagnosis and symptoms before starting treatment, and on panic and agoraphobic symptoms immediately after and one year after treatment. These interviews will be done by psychologists who are blinded for which type of treatment the patients have got.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Agoraphobia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Thought field therapy

24 randomly selected patients will be treated with 5 sessions of standard Thought field therapy.

Group Type EXPERIMENTAL

Thought field therapy

Intervention Type BEHAVIORAL

5 sessions with Thought field therapy

Cognitive therapy

Treatment with Cognitive therapy, 12 sessions with manualized therapy according to David Clark's model.

Group Type ACTIVE_COMPARATOR

Cognitive therapy

Intervention Type BEHAVIORAL

12 sessions of Cognitive therapy

Wait list

24 patients will be randomly selected to 3 months on a wait list, thereafter randomly selected to either Cognitive therapy or Thought field therapy.

Group Type OTHER

Wait list

Intervention Type BEHAVIORAL

3 months waiting, then randomized to either thought field therapy or cognitive therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thought field therapy

5 sessions with Thought field therapy

Intervention Type BEHAVIORAL

Cognitive therapy

12 sessions of Cognitive therapy

Intervention Type BEHAVIORAL

Wait list

3 months waiting, then randomized to either thought field therapy or cognitive therapy

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

TFT CBT WL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients ages 18 years or older,
* Patients with agoraphobia,
* Patients with a score on Mobility Inventory "Alone" of 2.5 or more,
* Patients who give a written consent to participate.

Exclusion Criteria

* Psychosis (past or present),
* Drug abuse or dependency,
* Moderate or high score on suicidal behaviour on the M.I.N.I.,
* Patients who have another illness (other than panic disorder or agoraphobia) and are in need of immediate treatment.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No